Sitravatinib
Sitravatinib (MGCD516) is an experimental drug for the treatment of cancer. It is a small molecule inhibitor of multiple tyrosine kinases. Reference standards of Sitravatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Sitravatinib - API Standards
[catalogue_number] => PA 19 1710000
[category_ids] => ,75,76,78,70,82,
[chemical_name] =>
[weight] => 629.68
[form] => C33H29F2N5O4S
[cas] => 1123837-84-2
[pslug] => 1123837-84-2-sitravatinib-api-pa191710000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Sitravatinib - API Standards
Catalogue No.:PA 19 1710000
Molecular Formula : C33H29F2N5O4S
Molecular Weight : 629.68